Kirshan Lal, MD
Hospitalist · Dayton, OHNPI 1316964398
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $20,825 of the $27,828 with a category attached, or 74.8%. 12 manufacturers reported payments, led by Pfizer at 43.9% of the total. Reporting peaked in 2019 at $16,237 and has fallen 80.7% since, to $3,133 in 2025. Among hospitalist clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 65 payments — averaging $428.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$12K
- E.r. Squibb & Sons, L.L.C.$9K
- Bayer$3K
- Hill-rom Holdings, Inc$800
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$723
- Boston Scientific$563
- plus $1K from 6 others
What the payments were for
- Consulting fees$3,11011%
- Speaking & faculty fees$20,82575%
- Travel & lodging$2561%
- Food & beverage$3,63713%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 16 | $12,206 |
| E.r. Squibb & Sons, L.L.C. | 8 | $9,064 |
| Bayer | 11 | $3,265 |
| Hill-rom Holdings, Inc | 1 | $800 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $723 |
| Boston Scientific | 7 | $563 |
| AstraZeneca(2 entities) | 6 | $551 |
| Novartis | 2 | $241 |
| Johnson & Johnson | 2 | $184 |
| Endologix LLC | 1 | $99 |
| Lilly USA, LLC | 1 | $74 |
| Astellas Pharma US Inc | 1 | $58 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,828 in reported general payments places this provider in the 95th percentile of 813 hospitalist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CefuroximeCefuroxime Axetil | 12 | $164 |
| Pantoprazole Sodium | 15 | $138 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $76 |
| Lisinopril | 15 | $52 |
| Prednisone | 14 | $18 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Dayton
- Thomas KoroscilDayton$4K
- Irina OvermanDayton$2K
- Johan WorndleDayton$1K
- Hari PolenakovikDayton$1K
- Bhumit PatelDayton$1K
- Kenechi ObettaDayton$1K
- Chandramohan MeenakshisundaramCleveland$54K
- Geeta SrivastavaCincinnati$10K
- Danielle ClemmerColumbus$9K
- Robert RubinCincinnati$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.